The Angiogenesis Inhibitor Vasostatin does not Impair Wound Healing at Tumor-Inhibiting Doses
- 1 November 2001
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 117 (5) , 1036-1041
- https://doi.org/10.1046/j.0022-202x.2001.01519.x
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healingThe FASEB Journal, 2000
- The Angiogenesis Inhibitor, Endostatin, Does Not Affect Murine Cutaneous Wound HealingJournal of Surgical Research, 2000
- Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawalJournal of Clinical Investigation, 1999
- Blood vessel maturation: vascular development comes of ageJournal of Clinical Investigation, 1999
- A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGFDevelopment, 1998
- Antiangiogenic therapy of experimental cancer does not induce acquired drug resistanceNature, 1997
- Reduced Expression of PDGF and PDGF Receptors During Impaired Wound HealingJournal of Investigative Dermatology, 1997
- Vascular development: cellular and molecular regulationThe FASEB Journal, 1997
- Basics of Cutaneous Wound RepairThe Journal of Dermatologic Surgery and Oncology, 1993
- Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule.The Journal of cell biology, 1991